newsfilter
← Latest News
ACCESS Newswire·

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

NEW YORK, NY / ACCESSWIRE / March 21, 2024 / Protagenic Therapeutics, Inc. , a biopharmaceutical innovator, regained compliance with Nasdaq Listing Rule 5550 as the closing bid price of shares of PTIX